Early stage DLBCL Tweetorial of all key trials from a presentation I just gave #Goodman_heme
See last slide/Tweet for my conclusions
SWOG 8736:
>18 years
Bulk (>10 cm) allowed
CHOPx 3+IFRT vs. CHOP x 3 +IFRT
OS⬆️with IFRT but no difference in OS with extended f/u
18 year f/u
ECOG 1484
>16 years
Bulk (>10 cm) allowed
CHOP x 8 if CR (by CT) randomized to IFRT vs observation
DFS improved with IFRT
No difference in OS
GELA/LNH 93-1
No adverse risk factors on aaIPI
Age <60 years
Bulk (> 10 cm) allowed
ACVBP x 3 vs CHOP x 3 + IFRT
EFS and OS improved with chemo alone
Very young favorable group but chemo alone works!
GELA/LNH 93-4
>60 years
No adverse risk factors on aaIPI
Bulk (>10 cm) allowed
CHOP x 4 vs CHOP x 4 +IFRT
No difference in EFS or OS
Chemo alone works
UNFOLDER
18-60 years
65% stage I/II
aaIPI 0 with bulk or 1🚫 bulk
Bulk allowed (>7.5 cm)
RCHOP21x6 vs RCHOP21x6 + IFRT vs RCHOP14 x 6 vs RCHOP14x6 + IFRT
⬆️EFS in IFRT, no difference in PFS/OS
EFS in patients no IFRT was linked to higher rate of PRs triggered additional Rx (XRT)
LYSA/GOELAMS 02-03
No bulk allowed (>7 cm)
RCHOP14 x 4 then PET/CT
IF CR on PET2 then
mIPI 0 observation
mIPI>0 RCHOP x 2
If PR on PET2 then
RCHOP14 x 2 + IFRT
No difference on EFS/OS between no XRT and RT
FLYER
No bulk (>7.5 cm)
aaIPI 0
RCHOP x 6 vs. RCHOP x 4 +R x2
No difference is PFS/OS
Chemoimmunotherapy alone works for very favorable early stage DLBCL
SWOG 1001
Any mIPI
No bulk (>10 cm)
RCHOP x 3 then PET/CT
If CR then RCHOP x 1
If PR then IFRT followed by Zevalin
5 PFS/OS the same
My conclusions I/II DLBCL
SWOG8736: CHOPx3 + IFRT = CHOPx8
GELA/LNH 93-1: Intensive chemo>CHOP/XRT for young fav dz, but toxic
GELA/LNH93-4: CHOPx4 = CHOPx4+IFRT for old fav dz
FLYER: RCHOPx6 = RCHOPx4 for young fav dz
SWOG1001: If PET2 CR after RCHOPx3 then IFRT may be avoided
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Two of these disease are seen often on both the heme consult service and boards.
Cold Agglutinin Disease
Hemolytic anemia precipitated by cold
Monoclonal IgM binds RBCs (I antigen), agglutination, and fixes complement in cold->hemolysis
DAT+ for C3 and - for IgG
Associated with IgM gammopathies/LPL
Polyclonal form after Mycoplasma infection
Rx = Rituximab